FDA whistle-blower urges Europe to reject Merck's Arcoxia

04/15/2007 | USA Today

FDA whistle-blower David Graham says European health authorities should reconsider their approval of Merck's arthritis painkiller Arcoxia, which he says is "clearly killing people." An FDA advisory panel last week recommended the agency not approve the drug for the U.S. market, but Merck said the "overall benefit-to-risk profile" favors Arcoxia.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA